VTAK Quote, Financials, Valuation and Earnings

Picard Medical has a net margin of -1037.17% compared to Catheter Precision, Inc.'s net margin of --. Catheter Precision, Inc.'s return on equity of -192.05% beat Picard Medical's return on equity of --.

Catheter Precision, Inc. has a consensus price target of --, signalling upside risk potential of 1496.69%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Catheter Precision, Inc. has higher upside potential than Picard Medical, analysts believe Catheter Precision, Inc. is more attractive than Picard Medical.

Catheter Precision, Inc. has a beta of -1.301, which suggesting that the stock is 230.084% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Catheter Precision, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Catheter Precision, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.

Catheter Precision, Inc. quarterly revenues are $226K, which are larger than Picard Medical quarterly revenues of --. Catheter Precision, Inc.'s net income of -$2.3M is higher than Picard Medical's net income of --. Notably, Catheter Precision, Inc.'s price-to-earnings ratio is 0.40x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Catheter Precision, Inc. is 11.19x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies, Inc. has a net margin of -1037.17% compared to Catheter Precision, Inc.'s net margin of 3.68%. Catheter Precision, Inc.'s return on equity of -192.05% beat Retractable Technologies, Inc.'s return on equity of -8.05%.

Catheter Precision, Inc. has a consensus price target of --, signalling upside risk potential of 1496.69%. On the other hand Retractable Technologies, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Catheter Precision, Inc. has higher upside potential than Retractable Technologies, Inc., analysts believe Catheter Precision, Inc. is more attractive than Retractable Technologies, Inc..

Catheter Precision, Inc. has a beta of -1.301, which suggesting that the stock is 230.084% less volatile than S&P 500. In comparison Retractable Technologies, Inc. has a beta of 1.133, suggesting its more volatile than the S&P 500 by 13.309%.

Catheter Precision, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Catheter Precision, Inc. pays -- of its earnings as a dividend. Retractable Technologies, Inc. pays out 1.94% of its earnings as a dividend. Retractable Technologies, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Catheter Precision, Inc. quarterly revenues are $226K, which are smaller than Retractable Technologies, Inc. quarterly revenues of $10.1M. Catheter Precision, Inc.'s net income of -$2.3M is lower than Retractable Technologies, Inc.'s net income of $371K. Notably, Catheter Precision, Inc.'s price-to-earnings ratio is 0.40x while Retractable Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Catheter Precision, Inc. is 11.19x versus 0.65x for Retractable Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

VolitionRX Ltd. has a net margin of -1037.17% compared to Catheter Precision, Inc.'s net margin of -862.39%. Catheter Precision, Inc.'s return on equity of -192.05% beat VolitionRX Ltd.'s return on equity of --.

Catheter Precision, Inc. has a consensus price target of --, signalling upside risk potential of 1496.69%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.50 which suggests that it could grow by 779.04%. Given that Catheter Precision, Inc. has higher upside potential than VolitionRX Ltd., analysts believe Catheter Precision, Inc. is more attractive than VolitionRX Ltd..

Catheter Precision, Inc. has a beta of -1.301, which suggesting that the stock is 230.084% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.

Catheter Precision, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Catheter Precision, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.

Catheter Precision, Inc. quarterly revenues are $226K, which are smaller than VolitionRX Ltd. quarterly revenues of $627.3K. Catheter Precision, Inc.'s net income of -$2.3M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Catheter Precision, Inc.'s price-to-earnings ratio is 0.40x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Catheter Precision, Inc. is 11.19x versus 19.49x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -1037.17% compared to Catheter Precision, Inc.'s net margin of 3.93%. Catheter Precision, Inc.'s return on equity of -192.05% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Catheter Precision, Inc. has a consensus price target of --, signalling upside risk potential of 1496.69%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 150.92%. Given that Catheter Precision, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Catheter Precision, Inc. is more attractive than Xtant Medical Holdings, Inc..

Catheter Precision, Inc. has a beta of -1.301, which suggesting that the stock is 230.084% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.

Catheter Precision, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Catheter Precision, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Catheter Precision, Inc. quarterly revenues are $226K, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Catheter Precision, Inc.'s net income of -$2.3M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Catheter Precision, Inc.'s price-to-earnings ratio is 0.40x while Xtant Medical Holdings, Inc.'s PE ratio is 58.61x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Catheter Precision, Inc. is 11.19x versus 0.65x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.